Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease
- 20 November 2009
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 111 (6) , 1275-1308
Abstract
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, affecting millions of people worldwide. Apart from age, the major risk factor identified so far for the sporadic form of AD is possession of the ɛ4 allele of apolipoprotein E (APOE), which is also a risk factor for coronary artery disease (CAD). Other apolipoproteins known to play an important role in CAD such as apolipoprotein B are now gaining attention for their role in AD as well. AD and CAD share other risk factors, such as altered cholesterol levels, particularly high levels of low density lipoproteins together with low levels of high density lipoproteins. Statins – drugs that have been used to lower cholesterol levels in CAD, have been shown to protect against AD, although the protective mechanism(s) involved are still under debate. Enzymatic production of the beta amyloid peptide, the peptide thought to play a major role in AD pathogenesis, is affected by membrane cholesterol levels. In addition, polymorphisms in several proteins and enzymes involved in cholesterol and lipoprotein transport and metabolism have been linked to risk of AD. Taken together, these findings provide strong evidence that changes in cholesterol metabolism are intimately involved in AD pathogenic processes. This paper reviews cholesterol metabolism and transport, as well as those aspects of cholesterol metabolism that have been linked with AD.Keywords
This publication has 437 references indexed in Scilit:
- Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of CholesterolCell, 2009
- Novel N-terminal Cleavage of APP Precludes Aβ Generation in ACAT-Defective AC29 CellsJournal of Molecular Neuroscience, 2008
- Ceramide: A common pathway for atherosclerosis?Atherosclerosis, 2008
- Knockdown of ACAT‐1 reduces amyloidogenic processing of APPFEBS Letters, 2007
- Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosisNeurochemistry International, 2006
- The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta AmyloidNeurochemical Research, 2006
- Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Brain Uptake of Circulating Apolipoproteins J and E Complexed to Alzheimer′s Amyloid βBiochemical and Biophysical Research Communications, 1994
- β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s DiseaseBiochemical and Biophysical Research Communications, 1994
- A specific apoprotein activator for lipoprotein lipaseBiochemical and Biophysical Research Communications, 1970